The role of polymorphisms genes of detoxification of xenobiotics in the development of endometriosis

The study analyzed whether polymorphisms in xenobiotic/detoxification and estrogen-metabolism genes (CYP1A1, CYP1A2, CYP19, and SULT1A1) are associated with adenomyosis using PCR-RFLP genotyping. It included 703 women, with 167 histologically confirmed adenomyosis cases versus 536 controls without proliferative uterine conditions, and collected clinical/anamnestic risk-factor data. The main finding was a significant increase in CYP1A1 rs variants in the adenomyosis group, including higher C allele frequency (30% vs 10.5%) and higher frequencies of the T/C genotype and C/C homozygotes, consistent with increased CYP1A1 activity and altered estrogen metabolites; the authors also reference conflicting prior literature about CYP1A1’s role in other gynecologic diseases. This paper is centrally about adenomyosis—specifically, genetic polymorphisms in estrogen metabolism/detoxification-related enzymes (especially CYP1A1) in adenomyosis development.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works